ArticleGynecologic oncology reports2025
Phase 2 study of Wee1 inhibitor adavosertib in recurrent uterine carcinosarcoma.
Stephanie Cham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleGynecologic oncology reports2025
Stephanie Cham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.